Postoperative Pain Market Outlook, Trends And Future Opportunities (2024-2031)

Postoperative Pain Market Outlook, Trends And Future Opportunities (2024-2031)

Postoperative Pain Market, By Drug Class (Non-steroidal anti-inflammatory drugs (NSAIDs), Opioids, Local anesthetics, Acetaminophen, Nerve blockers), By Route of Administration (Oral, Injection, Topical, Others (transdermal, inhaled, etc.)), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies, Others (clinics, long-term care, etc.)), By Surgery Type (Orthopedic, Obstetric and gynecologic, General, Cardiac, Neurological), By End Use (Hospitals, Clinics, Homecare, Others (ambulatory surgical centers, long-term care centers, etc.)), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.

  • Published On: Mar 2024
  • Author(s): Sagar Karlekar
  • Report ID: IDA70
  • Region: Global
  • Format: PDF/EXCEL

Table of Contents:

Chapter 1. Research Methodology and Scope

    • Market Segmentation and Scope
    • Regional Coverage
    • Objectives
    • Research Methodology

Chapter 2. Executive Summary

    • Market Landscape
    • Market Size & Forecast
    • Competitive Landscape

Chapter 3. Postoperative Pain Market: Drug Class Segment Market Trends, Size, and Future Outlook

    • Drug Class Segment Market Size (US$), CAGR (%), and Forecast (2023-2031)
    • Drug Class Segment Definitions, Technology Landscape
    • Drug Class Segment Market Drivers
      • Product Launches
      • Technology Launches
      • Increased surgical procedures
    • Drug Class Segment Market Restraints
      • Side effects of certain analgesics

Chapter 4. Postoperative Pain Market: Route of Administration Segment Market Trends, Size, and Future Outlook

    • Route of Administration Segment Market Size (US$), CAGR (%), and Forecast (2023-2031)
    • Route of Administration Segment Definitions, Technology Landscape
    • Route of Administration Segment Market Drivers
      • Rise in patient preference for non-invasive drug delivery
    • Route of Administration Segment Market Restraints
      • Limitations of topical and transdermal delivery

Chapter 5. Postoperative Pain Market: Distribution Channel Segment Market Trends, Size, and Future Outlook

    • Distribution Channel Segment Market Size (US$), CAGR (%), and Forecast (2023-2031)
    • Distribution Channel Segment Definitions, Technology Landscape
    • Distribution Channel Segment Market Drivers
      • Increased adoption of e-commerce and internet pharmacies
    • Distribution Channel Segment Market Restraints
      • Concerns over drug authenticity and availability issues

Chapter 6. Postoperative Pain Market: Surgery Type Segment Market Trends, Size, and Future Outlook

    • Surgery Type Segment Market Size (US$), CAGR (%), and Forecast (2023-2031)
    • Surgery Type Segment Definitions, Technology Landscape
    • Surgery Type Segment Market Drivers
      • Rise in cardiovascular and orthopedic procedures
    • Surgery Type Segment Market Restraints
      • Risks associated with certain surgeries

Chapter 7. Postoperative Pain Market: End Use Segment Market Trends, Size, and Future Outlook

    • End Use Segment Market Size (US$), CAGR (%), and Forecast (2023-2031)
    • End Use Segment Definitions, Technology Landscape
    • End Use Segment Market Drivers
      • Increase in ambulatory day care surgical centers
    • End Use Segment Market Restraints
      • Limited pain management infrastructure in emerging markets

Chapter 8. Postoperative Pain Market: Regional Market Trends, Size, and Future Outlook

    • North America
      • Trends, Market Size (US$), CAGR (%), and Future Outlook
      • Market Size (US$), CAGR (%), and Forecast (2023-2031)
      • Definitions, Technology Landscape
      • Market Drivers
        • High surgery volumes
      • Market Restraints
        • Stringent regulations
      • Competitive Outlook
    • Europe
      • Trends, Market Size (US$), CAGR (%), and Future Outlook
      • Market Size (US$), CAGR (%), and Forecast (2023-2031)
      • Definitions, Technology Landscape
      • Market Drivers
        • High surgery volumes
      • Market Restraints
        • Stringent regulations
      • Competitive Outlook
    • Asia Pacific
      • Trends, Market Size (US$), CAGR (%), and Future Outlook
      • Market Size (US$), CAGR (%), and Forecast (2023-2031)
      • Definitions, Technology Landscape
      • Market Drivers
        • High surgery volumes
      • Market Restraints
        • Stringent regulations
      • Competitive Outlook
    • Latin America
      • Trends, Market Size (US$), CAGR (%), and Future Outlook
      • Market Size (US$), CAGR (%), and Forecast (2023-2031)
      • Definitions, Technology Landscape
      • Market Drivers
        • High surgery volumes
      • Market Restraints
        • Stringent regulations
      • Competitive Outlook
    • Middle East & Africa
      • Trends, Market Size (US$), CAGR (%), and Future Outlook
      • Market Size (US$), CAGR (%), and Forecast (2023-2031)
      • Definitions, Technology Landscape
      • Market Drivers
        • High surgery volumes
      • Market Restraints
        • Stringent regulations
      • Competitive Outlook
  • Postoperative Pain Market: Competitive Landscape
      • Pfizer
        • Company Overview
        • Financial Outlook
        • Product Portfolio
        • Strategies
      • Novartis
        • Company Overview
        • Financial Outlook
        • Product Portfolio
        • Strategies
      • Teva Pharmaceutical
        • Company Overview
        • Financial Outlook
        • Product Portfolio
        • Strategies
      • Mylan
        • Company Overview
        • Financial Outlook
        • Product Portfolio
        • Strategies
      • Allergan
        • Company Overview
        • Financial Outlook
        • Product Portfolio
        • Strategies
      • Purdue Pharma
        • Company Overview
        • Financial Outlook
        • Product Portfolio
        • Strategies
      • Endo Pharmaceuticals
        • Company Overview
        • Financial Outlook
        • Product Portfolio
        • Strategies
      • AstraZeneca
        • Company Overview
        • Financial Outlook
        • Product Portfolio
        • Strategies
      • Johnson & Johnson
        • Company Overview
        • Financial Outlook
        • Product Portfolio
        • Strategies
      • GlaxoSmithKline
        • Company Overview
        • Financial Outlook
        • Product Portfolio
        • Strategies
  • Research Methodology
    • Primary Research
    • Secondary Research
    • Assumptions
    • IDataAcumen Analysis
    • Paid Databases
  • Appendix
    • About Us

Frequently Asked Questions

The current market size of the Postoperative Pain industry is USD 18.5 billion in 2023.

Rising surgical volumes, Growing geriatric population, Strong product pipeline, Investments in R&D, Favorable regulatory policies, Advancements in drug delivery technologies

Side effects of certain pain medications like opioids, Patent expiries of blockbuster drugs, Pricing pressure, Regulatory hurdles

The leading component segment in the Postoperative Pain Market is the opioids segment. Opioids are highly effective for acute postoperative pain management.

Some of the major players operating in the Postoperative Pain Market are Pfizer, Johnson & Johnson, AbbVie, Teva Pharmaceutical, Novartis, Allergan, etc.

The Postoperative Pain Market is projected to reach USD 32.3 billion by 2031 from USD 18.5 billion in 2023, growing at a CAGR of 7.2% during the forecast period.

Rising surgical volumes globally, Strong product pipeline, Growing geriatric population, Regulatory approvals for new therapies, Advancements in drug delivery technologies, Increased healthcare spending on pain management, Rising prevalence of chronic diseases necessitating surgeries